PMC:7299399 / 40955-41446
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T192 | 143-151 | Body_part | denotes | backbone | http://purl.org/sig/ont/fma/fma13478 |
T193 | 221-225 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T371 | 68-69 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T372 | 106-113 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T373 | 221-225 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T374 | 292-293 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T375 | 431-432 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T159 | 0-491 | Sentence | denotes | It took decades of trial and error, of progressive adjustments, and a few tragic mistakes to identify the viruses that could provide the ideal backbone to develop viral vectors able to ferry genetic cargo into the target cell.122 In the midst of that global challenge, nanotechnology offered a safer and more controllable alternative: to generate bespoke structures that could replace viral vectors and do the same job, delivering a payload from the point of injection to the site of action. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32519842-1303270-158544 | 226-229 | 1303270 | denotes | 122 |